ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SUBRAMANIAM JAGADEESAN MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 2888

$1.63M Total Retail Price of All Prescriptions

Rank: 52 out of 2888

781 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 781 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

13% of this provider’s 781 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 792 691 1 1
SIMVASTATIN 749 585 2 2
LISINOPRIL 578 469 3 3
METOPROLOL SUCCINATE 532 456 4 11
NAMENDA 519 514 5 34
NEXIUM 511 388 6 19
AMLODIPINE BESYLATE 502 446 7 5
OMEPRAZOLE 475 386 8 7
FUROSEMIDE 463 407 9 6
METFORMIN HCL 329 226 10 8
DONEPEZIL HCL 310 303 11 26
ZOLPIDEM TARTRATE 289 247 12 17
JANUVIA 280 241 13 48
TRAMADOL HCL 279 192 14 16
SERTRALINE HCL 258 206 15 27
LOSARTAN POTASSIUM 248 211 16 18
ALENDRONATE SODIUM 245 226 17 23
CARBIDOPA-LEVODOPA 242 230 18 113
ATORVASTATIN CALCIUM 220 201 19 9
TAMSULOSIN HCL 220 199 19 29
METOPROLOL TARTRATE 212 197 21 10
GABAPENTIN 210 168 22 13
WARFARIN SODIUM 182 168 23 22
POTASSIUM CHLORIDE 180 171 24 14
DICLOFENAC SODIUM 175 124 25 141
AZITHROMYCIN 171 126 26 38
ACTOS 167 158 27 108
ESCITALOPRAM OXALATE 161 128 28 62
HYDROCODONE-ACETAMINOPHEN 158 117 S3 29 4
MELOXICAM 157 112 30 31
CRESTOR 150 120 31 20
LOSARTAN-HYDROCHLOROTHIAZIDE 144 112 32 46
BUPROPION XL 142 103 33 212
CLOPIDOGREL 139 117 34 30
METFORMIN HCL ER 132 106 35 53
LANTUS SOLOSTAR 130 91 36 92
ATENOLOL 128 84 37 25
DIOVAN 126 115 38 35
LEVOFLOXACIN 125 111 39 57
CITALOPRAM HBR 125 110 39 24
PANTOPRAZOLE SODIUM 124 109 41 33
TRIAMCINOLONE ACETONIDE 123 108 42 145
HYDROCHLOROTHIAZIDE 119 94 43 15
POLYETHYLENE GLYCOL 3350 114 106 44 93
VESICARE 113 96 45 154
PLAVIX 110 92 46 40
OLANZAPINE 104 104 47 137
EXELON 103 103 48 106
LYRICA 103 70 48 69
LANTUS 102 91 50 45
CYMBALTA 102 83 50 44
DIOVAN HCT 100 100 52 61
ROPINIROLE HCL 99 99 53 115
ZETIA 97 56 54 81
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 75 55 88
CARVEDILOL 95 80 55 21
PEN NEEDLE 93 52 57 110
MIRTAZAPINE 92 89 58 54
TRAZODONE HCL 89 67 59 43
GLYBURIDE-METFORMIN HCL 85 69 R 60 64
PRAVASTATIN SODIUM 84 73 61 12
HYDRALAZINE HCL 83 71 62 59
TIZANIDINE HCL 82 43 63 133
PREDNISONE 81 69 64 42
INSULIN SYRINGE 81 46 64 86
GLYBURIDE MICRONIZED 79 59 R 66 324
DIGOXIN 76 72 67 55
ISOSORBIDE MONONITRATE ER 75 58 68 51
ALBUTEROL SULFATE 74 64 69 134
CLONIDINE HCL 74 55 69 39
PHENYTOIN SODIUM EXTENDED 73 44 71 128
NIFEDIPINE ER 73 63 71 76
AVODART 71 65 73 151
BUMETANIDE 71 56 73 203
VYTORIN 71 65 73 155
RAMIPRIL 71 61 73 73
ALLOPURINOL 70 63 77 37
GLIMEPIRIDE 70 57 77 36
LEVEMIR FLEXPEN 70 56 77 156
DOXAZOSIN MESYLATE 70 53 77 94
NOVOLIN R 66 63 81 109
AMLODIPINE BESYLATE-BENAZEPRIL 65 57 82 67
TRAMADOL HCL-ACETAMINOPHEN 63 36 83 95
CILOSTAZOL 62 62 84 165
METHYLPREDNISOLONE 61 51 85 101
CIPROFLOXACIN HCL 57 46 86 47
BYSTOLIC 57 40 86 99
SINGULAIR 56 38 88 85
CYCLOBENZAPRINE HCL 56 17 R 88 68
CLOTRIMAZOLE-BETAMETHASONE 55 37 90 136
MEGESTROL ACETATE 53 53 R 91 140
PRAMIPEXOLE DIHYDROCHLORIDE 53 52 91 202
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 44 93 28
AMITRIPTYLINE HCL 50 27 R 94 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.